Follow this preprint
COVID19 Real-World Data for the US and Lessons to Re-Open Business
View ORCID ProfilePascal J. Goldschmidt-Clermont
doi: https://doi.org/10.1101/2020.06.02.20120618
Now published in PLOS Pathogens doi: 10.1371/journal.ppat.1008756
Pascal J. Goldschmidt-Clermont
1Lennar Corporation,
M.D.Roles: Chief Medical Officer

Data Availability
All anonymized data is available upon request
Posted June 10, 2020.
COVID19 Real-World Data for the US and Lessons to Re-Open Business
Pascal J. Goldschmidt-Clermont
medRxiv 2020.06.02.20120618; doi: https://doi.org/10.1101/2020.06.02.20120618
Now published in PLOS Pathogens doi: 10.1371/journal.ppat.1008756
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (423)
- Allergy and Immunology (746)
- Anesthesia (217)
- Cardiovascular Medicine (3215)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13229)
- Forensic Medicine (19)
- Gastroenterology (887)
- Genetic and Genomic Medicine (5053)
- Geriatric Medicine (469)
- Health Economics (772)
- Health Informatics (3174)
- Health Policy (1126)
- Hematology (421)
- HIV/AIDS (998)
- Medical Education (467)
- Medical Ethics (125)
- Nephrology (513)
- Neurology (4794)
- Nursing (253)
- Nutrition (712)
- Oncology (2470)
- Ophthalmology (699)
- Orthopedics (278)
- Otolaryngology (337)
- Pain Medicine (319)
- Palliative Medicine (89)
- Pathology (528)
- Pediatrics (1274)
- Primary Care Research (548)
- Public and Global Health (7357)
- Radiology and Imaging (1666)
- Respiratory Medicine (965)
- Rheumatology (472)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (69)
- Transplantation (229)
- Urology (199)